GFC Life Science Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on GFC Life Science's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Chemicals Industry Growth	13.95%
Revenue growth rate	n/a
Return on equity	n/a
Net Margin	n/a
Last Earnings Update	31 Dec 2021

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How GFC Life Science makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A388610 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 21	13,737	1,641	3,743	841
31 Dec 20	13,324	-2,407	4,516	968
31 Dec 19	11,908	449	3,467	695
31 Dec 18	8,679	-500	2,907	1,200
31 Dec 17	7,161	-935	2,030	1,648
31 Dec 16	7,006	1,419	1,496	1,422

Quality Earnings: Insufficient data to determine if A388610 has high quality earnings.

Growing Profit Margin: Insufficient data to determine if A388610's profit margins have improved over the past year.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if A388610's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare A388610's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if A388610's earnings growth over the past year exceeded the Chemicals industry average.

Return on Equity

High ROE: A388610 has a negative Return on Equity (0%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/12/19 06:10
End of Day Share Price	2025/12/19 00:00
Earnings	2021/12/31
Annual Earnings	2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

GFC Life Science Co., Ltd is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Jongsun Park	Eugene Investment & Securities Co Ltd.
Jun Ki Baek	NH Investment & Securities Co., Ltd.